Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Primidone
Drug ID BADD_D01840
Description Primidone is an anticonvulsant used to treat essential tremor as well as grand mal, psychomotor, and focal epileptic seizures.[L11112] Primidone was developed by J Yule Bogue and H C Carrington in 1949.[A189522] Primidone was granted FDA Approval on 8 March 1954.[L11112]
Indications and Usage For the treatment of epilepsy
Marketing Status Prescription; Discontinued
ATC Code N03AA03
DrugBank ID DB00794
KEGG ID D00474
MeSH ID D011324
PubChem ID 4909
TTD Drug ID D0U5RT
NDC Product Code 68084-202; 71610-079; 59348-0001; 72789-178; 63629-7811; 71610-191; 72789-177; 66490-691; 0615-8206; 65162-545; 17205-308; 71610-540; 71610-590; 0527-1301; 65162-544; 17205-307; 68682-690; 71610-005; 50090-1622; 55111-477; 53746-544; 42291-509; 50268-687; 0527-1231; 69584-685; 0904-5559; 72189-216; 69575-4045; 55111-876; 69584-684; 50268-686; 55111-476; 42291-511; 68084-203; 53746-545; 71335-1158; 68682-691; 0591-5321; 51927-2339; 10135-522; 66490-690; 71335-1965; 50090-4083; 49452-6020; 10135-540
Synonyms Primidone | Liskantin | Mylepsinum | Resimatil | Desoxyphenobarbital | Mizodin | Mysoline | Apo-Primidone | Apo Primidone | Primaclone | Sertan | Misodine | Primidon Holsten
Chemical Information
Molecular Formula C12H14N2O2
CAS Registry Number 125-33-7
SMILES CCC1(C(=O)NCNC1=O)C2=CC=CC=C2
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Hepatic cirrhosisAlanine aminotransferase 1P24298Not Available3997653; 7118708; 6698876
Hepatic cirrhosisAlanine aminotransferase 1P24298Not Available6648747; 6518350; 3510392; 7049029
JaundiceAlanine aminotransferase 1P24298Not Available6648747; 6518350; 3510392; 7049029
JaundiceGlutathione hydrolase 7Q9UJ14T251226648747; 6518350; 3510392; 7049029
JaundiceAlkaline phosphatase, tissue-nonspecific isozymeP05186T095386648747; 6518350; 3510392; 7049029
JaundiceAlanine aminotransferase 1P24298Not Available3997653; 7118708; 6698876
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Nervous system disorder17.02.10.001--Not Available
Nystagmus17.02.02.006; 06.05.02.006--
Personality change19.05.01.006; 17.02.05.019--
Peyronie's disease21.12.01.0020.003092%Not Available
Rash23.03.13.0010.001546%Not Available
Rash morbilliform23.03.13.005--Not Available
Seizure17.12.03.0010.001546%
Skin disorder23.03.03.007--Not Available
Somnolence19.02.05.003; 17.02.04.006--
Suicidal ideation19.12.01.003--
Suicide attempt19.12.01.0040.001546%
Systemic lupus erythematosus23.03.02.006; 15.06.02.003; 10.04.03.004--Not Available
Talipes15.11.07.007; 03.11.07.0070.001546%Not Available
Tremor17.01.06.0020.001546%
Vertigo17.02.12.002; 04.04.01.003--
Visual impairment06.02.06.008--Not Available
Vomiting07.01.07.003--
Lymphatic disorder01.09.01.003--Not Available
Musculoskeletal discomfort15.03.04.001--Not Available
Connective tissue disorder15.06.01.006--Not Available
Malnutrition14.03.02.004--Not Available
Mental disorder19.07.01.002--Not Available
Decreased appetite14.03.01.005; 08.01.09.0280.001546%
Erectile dysfunction21.03.01.007; 19.08.04.001--
Blood disorder01.05.01.004--Not Available
Psychotic disorder19.03.01.002--
Muscle contracture15.03.01.010--Not Available
Suicidal behaviour19.12.01.006--Not Available
Microtia04.06.01.005; 03.13.01.0060.001546%Not Available
Plantar fascial fibromatosis15.03.03.0120.003092%Not Available
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages